Sustainability | June 04, 2022
Organon introduces global ESG strategy
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
The product will be manufactured at Lupin’s Nagpur facility in India
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Rocuronium Bromide Injection is a neuromuscular blocking agent
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.
Subscribe To Our Newsletter & Stay Updated
